The diagnostic value of tumor markers in bronchoalveolar lavage fluid for the peripheral pulmonary carcinoma

被引:10
作者
Zhang, Shi [1 ]
Zhao, Yun-feng [2 ]
Zhang, Ming-zhou [1 ]
Wu, Xue-ling [1 ]
机构
[1] Third Mil Med Univ, Xinqiao Hosp, Inst Resp Med, Chongqing 400037, Peoples R China
[2] Pudong New Area Gongli Hosp, Dept Resp Med, Shanghai 200135, Peoples R China
基金
中国国家自然科学基金;
关键词
bronchoalveolar lavage fluid; marker; peripheral pulmonary carcinoma; diagnosis; CELL LUNG-CANCER; S-TRANSFERASE-PI; BIOMARKERS; SURVIVAL; USP8;
D O I
10.1111/crj.12362
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
BackgroundTo investigate the value of Ubiquitin specific peptidase 8 (USP8), Chitinase 3-like 1 (YKL40), Heat shock protein 90a (HSP90), glutathione S-transferase P1 (GSTP1), carcinoembryonic antigen (CEA), neuron specific enolase (NSE) and cytokeratin fragment antiogen 21-1 (CYFRA21-1) in bronchoalveolar lavage fluid (BALF) and serum for diagnosis in patients with peripheral lung cancer. MethodsThe concentration of these markers were measured in 50 patients with peripheral lung cancer and 50 patients with benign lung diseases by using enzyme-linked immuno sorbent assay methods. ResultsThere were significant differences between the peripheral lung cancer group and the benign lung disease group (P<0.05) in the BALF of USP8, YKL40, HSP90, CEA, NSE and CYFRA21-1. There were significant differences between the peripheral lung cancer group and the benign lung disease group (P<0.05) in the serum of HSP90 and CEA. There were no differences in others. There were no correlation between the concentration of all markers and age, histological type, TNM stage (I-IV). There was a weak correlation between the primary foci diameters and the concentration of YKL40 in BALF. (Pearson's correlation: 0.203, P=0.048) The diagnostic efficiencies of USP8, YKL40, HSP90 were superior to CYFRA21-1 and NSE, being lower CEA.Conclusion: Detection of tumor markers in BALF was superior to serum specimens. The measurement of USP8, HSP90 and YKL40 in BALF had more clinical value for the diagnosis of peripheral pulmonary carcinoma.
引用
收藏
页码:481 / 488
页数:8
相关论文
共 32 条
  • [1] [Anonymous], PNEUMOLOGIA
  • [2] Baykara M, 2013, J BUON, V18, P921
  • [3] Biomarker analysis from a pathologist's view. Founding the rationale for personalised treatment of lung cancer
    Buettner, R.
    Heydt, C.
    [J]. BUNDESGESUNDHEITSBLATT-GESUNDHEITSFORSCHUNG-GESUNDHEITSSCHUTZ, 2013, 56 (11) : 1502 - 1508
  • [4] Mitoxantrone Targets Human Ubiquitin-Specific Peptidase 11 (USP11) and Is a Potent Inhibitor of Pancreatic Cancer Cell Survival
    Burkhart, Richard A.
    Peng, Yu
    Norris, Zoe A.
    Tholey, Renee M.
    Talbott, Vanessa A.
    Liang, Qin
    Ai, Yongxing
    Miller, Kathy
    Lal, Shruti
    Cozzitorto, Joseph A.
    Witkiewicz, Agnieska K.
    Yeo, Charles J.
    Gehrmann, Matthew
    Napper, Andrew
    Winter, Jordan M.
    Sawicki, Janet A.
    Zhuang, Zhihao
    Brody, Jonathan R.
    [J]. MOLECULAR CANCER RESEARCH, 2013, 11 (08) : 901 - 911
  • [5] USP8 Is a Novel Target for Overcoming Gefitinib Resistance in Lung Cancer
    Byun, Sanguine
    Lee, Sung-Young
    Lee, Jihoon
    Jeong, Chul-Ho
    Farrand, Lee
    Lim, Semi
    Reddy, Kanamata
    Kim, Ji Young
    Lee, Mee-Hyun
    Lee, Hyong Joo
    Bode, Ann M.
    Lee, Ki Won
    Dong, Zigang
    [J]. CLINICAL CANCER RESEARCH, 2013, 19 (14) : 3894 - 3904
  • [6] Lung Cancer Biomarkers Present Status and Future Developments
    Cagle, Philip T.
    Allen, Timothy Craig
    Olsen, Randall J.
    [J]. ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 2013, 137 (09) : 1191 - 1198
  • [7] Evaluation of VEGF-C and Tumor Markers in Bronchoalveolar Lavage Fluid for Lung Cancer Diagnosis
    Cao, Chao
    Chen, Zhong-Bo
    Sun, Shi-Fang
    Yu, Yi-Ming
    Ding, Qun-Li
    Deng, Zai-Chun
    [J]. SCIENTIFIC REPORTS, 2013, 3
  • [8] Landscape of the mitochondrial Hsp90 metabolome in tumours
    Chae, Young Chan
    Angelin, Alessia
    Lisanti, Sofia
    Kossenkov, Andrew V.
    Speicher, Kaye D.
    Wang, Huan
    Powers, James F.
    Tischler, Arthur S.
    Pacak, Karel
    Fliedner, Stephanie
    Michalek, Ryan D.
    Karoly, Edward D.
    Wallace, Douglas C.
    Languino, Lucia R.
    Speicher, David W.
    Altieri, Dario C.
    [J]. NATURE COMMUNICATIONS, 2013, 4
  • [9] DisPietro G, 2010, EXPERT OPIN DRUG MET, V6, P153
  • [10] Dragomir Antonela, 2011, Pneumologia, V60, P9